LON:GDR genedrive Share Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding genedrive plc Please log in to your account or sign up in order to add this asset to your watchlist. GBX 18.27 -1.23 (-6.31%) (As of 06/27/2022 12:41 PM ET) Add Compare Share Today's Range 18.23▼ 2050-Day Range 17.85▼ 3052-Week Range 10▼ 82Volume320,296 shsAverage Volume3.04 million shsMarket Capitalization£16.91 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsEarningsInsider TradesHeadlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive GDR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for genedrive and its competitors with MarketBeat's FREE daily newsletter. Email Address GDR Stock Forecast (MarketRank)Overall MarketRank™0.96 out of 5 starsAnalyst Opinion: 0.0Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 - 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for genedrive. Previous Next 4.8 Community Rank Outperform Votesgenedrive has received 242 “outperform” votes. (Add your “outperform” vote.)Underperform Votesgenedrive has received 91 “underperform” votes. (Add your “underperform” vote.)Community Sentimentgenedrive has received 72.67% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about genedrive and other stocks. Vote “Outperform” if you believe GDR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe GDR will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend Yieldgenedrive does not currently pay a dividend.Dividend Growthgenedrive does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, genedrive insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of genedrive is -3.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of genedrive is -3.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share Ratiogenedrive has a P/B Ratio of 2.19. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About genedrive (LON:GDR)genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive, a patented small polymerase chain reaction, which enables rapid nucleic acid amplification and detection from various sample types, including plasma, sputum, and buccal swabs. Its Genedrive platform offers Genedrive HCV ID Kit, a qualitative molecular solution for Hepatitis C Virus testing; Genedrive BioPlex for the rapid determination of military biothreats from pathogens; Genedrive MT-RNR1-ID Kit, a rapid genetic test in an emergency neonatal care setting; and Genedrive Connect app, an android-based mobile app that allows added data management flexibility and results transmission. The company serves biotechnology and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. It has a collaboration agreement with Beckman Coulter Life Sciences to automate the laboratory PCR testing process for COVID-19. The company was formerly known as Epistem Holdings Plc and changed its name to genedrive plc in July 2016. genedrive plc was founded in 2000 and is headquartered in Manchester, the United Kingdom.Read More GDR Stock News HeadlinesJune 17, 2022 | finance.yahoo.comgenedrive plc (GDR.L)May 30, 2022 | proactiveinvestors.comGenedrive gets UK coronavirus test device approvalMay 13, 2022 | finance.yahoo.comWe Think genedrive (LON:GDR) Needs To Drive Business Growth CarefullyMarch 29, 2022 | lse.co.ukGenedrive soars as UK public health body reviews hearing loss testMarch 29, 2022 | marketwatch.comGenedrive Swung to 1H Pretax Loss; Confident in Commercial ProgressMarch 29, 2022 | proactiveinvestors.comTen Entertainment back in profit and upbeat about outlookMarch 18, 2022 | marketwatch.comGenedrive Shares Rise on First Deployments of Screening System for UK's NHSMarch 2, 2022 | lse.co.ukGenedrive finance chief announces April departureMarch 2, 2022 | marketwatch.comGenedrive's CFO Matthew Fowler to Leave in AprilFebruary 23, 2022 | lse.co.ukGenedrive makes progress with rapid Covid-19 test kitFebruary 12, 2022 | finance.yahoo.comMarket Sentiment Around Loss-Making genedrive plc (LON:GDR)December 22, 2021 | lse.co.ukGenedrive shares soar as files for UK approval of Covid testing kitDecember 14, 2021 | fool.co.ukThe Genedrive share price is up over 230% in one month! Is there more to come?See More Headlines Industry, Sector and Symbol Stock ExchangeLON Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolLON:GDR Previous SymbolLON:EHP CUSIPN/A CIKN/A Webwww.genedriveplc.com Phone+44-161-9890245FaxN/AEmployees46Year FoundedN/ACompany Calendar Last Earnings2/04/2020Today6/27/2022Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio0.09 P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.44 Current Ratio6.77 Quick Ratio6.22 Sales & Book Value Annual Sales£334 thousand Price / Sales50.62 Cash FlowGBX 6.60 per share Price / Cash Flow2.77 Book ValueGBX 8.60 per share Price / Book2.12Miscellaneous Outstanding Shares92,535,000Free FloatN/AMarket Cap£16.91 million OptionableNot Optionable BetaN/A genedrive Frequently Asked Questions How has genedrive's stock performed in 2022? genedrive's stock was trading at GBX 43 at the beginning of the year. Since then, GDR stock has decreased by 57.5% and is now trading at GBX 18.27. View the best growth stocks for 2022 here. How were genedrive's earnings last quarter? genedrive plc (LON:GDR) posted its quarterly earnings data on Tuesday, February, 4th. The company reported ($8.90) EPS for the quarter. View genedrive's earnings history. Who are genedrive's key executives? genedrive's management team includes the following people: Mr. David Budd, CEO & Exec. Director (Age 54, Pay $242.19k)Mr. Russell John Shaw, Chief Financial Officer & Director (Age 44) Who are some of genedrive's key competitors? Some companies that are related to genedrive include Akumin (AKU), SQI Diagnostics (SQD), Oncimmune (ONC), Yourgene Health (YGEN), VentriPoint Diagnostics (VPT), Verici Dx (VRCI), Cambridge Cognition (COG), GeneNews (GEN), LexaGene (LXG), GENinCode (GENI), LED Medical Diagnostics (LMD), Abingdon Health (ABDX), Integrated Diagnostics (IDHC), Deepmatter Group (DMTR) and 3D Signatures (DXD). View all of GDR's competitors. What other stocks do shareholders of genedrive own? Based on aggregate information from My MarketBeat watchlists, some companies that other genedrive investors own include NVIDIA (NVDA), Altria Group (MO), Netflix (NFLX), SolGold (SOLG), Tiziana Life Sciences (TILS), Asbury Automotive Group (ABG), Allena Pharmaceuticals (ALNA), Amphenol (APH), Benchmark Electronics (BHE) and Bank of New York Mellon (BK). What is genedrive's stock symbol? genedrive trades on the London Stock Exchange (LON) under the ticker symbol "GDR." How do I buy shares of genedrive? Shares of GDR and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is genedrive's stock price today? One share of GDR stock can currently be purchased for approximately GBX 18.27. How much money does genedrive make? genedrive (LON:GDR) has a market capitalization of £16.91 million and generates £334 thousand in revenue each year. How many employees does genedrive have? genedrive employs 46 workers across the globe. How can I contact genedrive? genedrive's mailing address is 48 Grafton Street, MANCHESTER, M13 9XX, United Kingdom. The official website for genedrive is www.genedriveplc.com. The company can be reached via phone at +44-161-9890245. This page (LON:GDR) was last updated on 6/27/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
